Pricing and Value Strategy

Emerging discussions with the commercial team lacked clarity on value benchmarks, comparator landscapes, and stakeholder willingness to pay, and a connectedness to upstream and downstream activities across medical, value, access teams, at a sub-national, national, regional and global level.

A novel pricing and access strategy and lifecycle forecasting and management tool were built using TPP benchmarking, early economic modelling, and strategic landscape synthesis.